These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17922863)

  • 1. Rationale and clinical implication of combined chemotherapy with cisplatin and oestrogen in prostate cancer: primary evidence based on methylation analysis of oestrogen receptor-alpha.
    Moriyama-Gonda N; Shiina H; Terashima M; Satoh K; Igawa M
    BJU Int; 2008 Feb; 101(4):485-91. PubMed ID: 17922863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of estrogen receptor-alpha expression is associated with hypermethylation near its ATG start codon in gastric cancer cell lines.
    Woo IS; Park MJ; Choi SW; Kim SJ; Lee MA; Kang JH; Hong YS; Lee KS
    Oncol Rep; 2004 Mar; 11(3):617-22. PubMed ID: 14767512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent methylation of estrogen receptor in prostate cancer: correlation with tumor progression.
    Li LC; Chui R; Nakajima K; Oh BR; Au HC; Dahiya R
    Cancer Res; 2000 Feb; 60(3):702-6. PubMed ID: 10676656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
    Freedland SJ; Seligson DB; Liu AY; Pantuck AJ; Paik SH; Horvath S; Wieder JA; Zisman A; Nguyen D; Tso CL; Palotie AV; Belldegrun AS
    Prostate; 2003 Apr; 55(1):71-80. PubMed ID: 12640663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytoestrogens from Belamcanda chinensis regulate the expression of steroid receptors and related cofactors in LNCaP prostate cancer cells.
    Thelen P; Peter T; Hünermund A; Kaulfuss S; Seidlová-Wuttke D; Wuttke W; Ringert RH; Seseke F
    BJU Int; 2007 Jul; 100(1):199-203. PubMed ID: 17488304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation regulates the expression of Y chromosome specific genes in prostate cancer.
    Dasari VK; Deng D; Perinchery G; Yeh CC; Dahiya R
    J Urol; 2002 Jan; 167(1):335-8. PubMed ID: 11743352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of the ASC gene promoter is associated with aggressive prostate cancer.
    Collard RL; Harya NS; Monzon FA; Maier CE; O'Keefe DS
    Prostate; 2006 May; 66(7):687-95. PubMed ID: 16425203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers.
    Archey WB; McEachern KA; Robson M; Offit K; Vaziri SA; Casey G; Borg A; Arrick BA
    Oncogene; 2002 Oct; 21(46):7034-41. PubMed ID: 12370825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of human estrogen receptor (ER) gene alpha and beta in prostate cancer PC-EW and PC-OR cell lines.
    Bergner CC; Krause FS; Zugor V; Rith T; Schrott KM; Endele S; Engehausen DG
    Anticancer Res; 2007; 27(4A):2071-4. PubMed ID: 17649823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer.
    Ho SM; Leung YK; Chung I
    Ann N Y Acad Sci; 2006 Nov; 1089():177-93. PubMed ID: 17261766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of paclitaxel-induced thymidine phosphorylase expression can accelerate apoptosis in human prostate cancer cells.
    Kikuno N; Moriyama-Gonda N; Yoshino T; Yoneda T; Urakami S; Terashima M; Yoshida M; Kishi H; Shigeno K; Shiina H; Igawa M
    Cancer Res; 2004 Oct; 64(20):7526-32. PubMed ID: 15492279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers.
    Iwase H; Omoto Y; Iwata H; Toyama T; Hara Y; Ando Y; Ito Y; Fujii Y; Kobayashi S
    Br J Cancer; 1999 Aug; 80(12):1982-6. PubMed ID: 10471050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines.
    Kim IY; Kim BC; Seong DH; Lee DK; Seo JM; Hong YJ; Kim HT; Morton RA; Kim SJ
    Cancer Res; 2002 Sep; 62(18):5365-9. PubMed ID: 12235008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy.
    Bastian PJ; Ellinger J; Heukamp LC; Kahl P; Müller SC; von Rücker A
    Eur Urol; 2007 Mar; 51(3):665-74; discussion 674. PubMed ID: 16956712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
    J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone receptor B (PRB) promoter hypermethylation in sporadic breast cancer: progesterone receptor B hypermethylation in breast cancer.
    Mc Cormack O; Chung WY; Fitzpatrick P; Cooke F; Flynn B; Harrison M; Fox E; Gallagher E; McGoldrick A; Dervan PA; McCann A; Kerin MJ
    Breast Cancer Res Treat; 2008 Sep; 111(1):45-53. PubMed ID: 17896177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen promoter driven gene therapy targeting DNA polymerase-alpha and topoisomerase II alpha in prostate cancer.
    Lee CH; Liu M; Sie KL; Lee MS
    Anticancer Res; 1996; 16(4A):1805-11. PubMed ID: 8712704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells.
    Myrthue A; Rademacher BL; Pittsenbarger J; Kutyba-Brooks B; Gantner M; Qian DZ; Beer TM
    Clin Cancer Res; 2008 Jun; 14(11):3562-70. PubMed ID: 18519790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of oestrogen receptor-alpha and oestrogen receptor-beta in prostate cancer.
    Yang GS; Wang Y; Wang P; Chen ZD
    Chin Med J (Engl); 2007 Sep; 120(18):1611-5. PubMed ID: 17908481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.